Markets Published June 6, 2016 1:04pm EDT | Updated November 23, 2017 9:06pm EST Vascular Biogenics Stock Up 34% In Pre-market Trade After Positive Cancer Drug Trial Results Comments By Emma R. Court MarketWatch Pulse